Navigation Links
Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC)

involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in such forward looking statements. The company undertakes no obligation to update or revise any forward-looking statements.

Company and Investor Relation Contacts:

Oramed Pharmaceuticals

Eric Rosenberg

Cell: +972-54-566-7713

Office: +972-2-566-0001


Media Contacts:

Ruder Finn Israel for Oramed

Matthew Krieger

Cell: +972-54-467-6950

Office: +972-2-589-2003


SOURCE Oramed Pharmaceticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
2. Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)
3. Israels Prestigious Presidents Conference to Feature Oramed Pharmaceuticals Revolutionary Oral Insulin Capsule
4. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
5. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008
6. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
7. Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
8. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
9. Memory Pharmaceuticals Provides Update on NASDAQ Listing Status
10. BioWa Announces License of Biowas Potelligent(R) Technology to KaloBios Pharmaceuticals
11. Potentia Pharmaceuticals to Present ASaP Phase I Clinical Trial Data for POT-4 at the American Academy of Ophthalmology Annual Meeting
Post Your Comments:
(Date:10/9/2015)... , Oct. 9, 2015 Governor ... clinical stage biopharmaceutical company focused on developing T-cell receptor ... high-paying jobs with a new expansion project. ... news for the commonwealth as 110 new, high-paying jobs ... Tom Wolf . "My budget proposal includes sustained funding ...
(Date:10/9/2015)... SAN DIEGO , Oct. 9, 2015  DePuy ... ® Flex with Q-PACK ®  Technology**, the ... use in trauma-related extremity procedures (foot and ankle, hand ... The announcement was made here at the 2015 Orthopaedic ... (provides a natural scaffold for new bone growth) ...
(Date:10/9/2015)... ... October 09, 2015 , ... From blood to food to ... cells from their surroundings for research, diagnostics, and cell therapy—also known as cell ... Ann Arbor-based startup Akadeum Life Sciences is developing a radically new ...
(Date:10/8/2015)... USA, and CARDIFF, UK (PRWEB) , ... October 08, 2015 , ... ... imaging technology to literally see inside the living brain, providing a new tool to ... , The work is reported by Woo June Choi and Ruikang Wang of the ...
Breaking Biology Technology:
... a Tulsa heart-care center, announced on Monday that with ... installed of a new information technology system to handle ... eliminating all paper records and charts within the hospital. ... around GEs Centricity Clinical Information System, which integrates patient ...
... A few months back I wrote about the negative effects ... that most problems in business can be solved by changing ... , ,The process management view of sorting out problems is ... isnt working as designed or wasnt designed properly in the ...
... cells, some of which are affected by sickle-cell anemia. ... Third Wave Technologies , a Madison-based provider of ... sued the California-based Stratagene Corp. to defend ... patented the technology used in Stratagenes probe-based quantitative ...
Cached Biology Technology:
(Date:10/1/2015)... YORK , Oct. 1, 2015  Biometrics ... and analysing human body characteristics, such as fingerprints, ... authentication purposes. Adoption of biometrics technology has been ... over the last five years. In addition to ... that is fingerprint recognition, other means of biometric ...
(Date:9/30/2015)...  The global glucose monitoring device and diabetes management market ... new report on the industry from Kalorama Information. Sales in the ... followed by continuous glucose monitoring and sensor segment, according to ... these products in its latest report, The Global Glucose ... , ...
(Date:9/28/2015)... Sept. 28, 2015 CLEAR, the ... its expedited traveler service is coming to ... travel, bringing a frictionless experience, serious speed ... "CLEAR offers our travelers an expedited ... said Jim Smith , Executive Director, ...
Breaking Biology News(10 mins):
... Mich. Why, after millions of years of evolution, ... A study conducted at Michigan State University and ... Naturalist investigates the evolutionary reasons why organisms go ... build tissues and structures they don,t appear to use, ...
... Many of us are familiar with prion disease from its ... (bovine spongiform encephalopathy) that created a crisis in the global ... illness affecting a tribe in Papua New Guinea known for ... the abnormal folding of a protein and resulting in progressive ...
... North American freshwater fishes are going extinct at an alarming ... the September issue of BioScience . The rate ... off in the past decade. The number of extinct species ... article, by Noel M. Burkhead of the US Geological Survey, ...
Cached Biology News:
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L....
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
The BD OptEIA Rat TNF-alpha ELISA Kit is for the quantitative determination of TNF-alpha in rat serum, plasma and cell culture supernatant....
Biology Products: